PMIDA-Modified Fe3O4 Magnetic Nanoparticles: Synthesis and Application for Liver MRI; Langmuir; Vol. 34, iss. 11

PMIDA-Modified Fe3O4 Magnetic Nanoparticles: Synthesis and Application for Liver MRI; Langmuir; Vol. 34, iss. 11

Detalhes bibliográficos
Parent link:Langmuir
Vol. 34, iss. 11.— 2018.— [P. 3449-3458]
Autor Corporativo: Национальный исследовательский Томский политехнический университет Исследовательская школа химических и биомедицинских технологий (ИШХБМТ)
Outros Autores: Demin A. M. Aleksandr Mikhaylovich, Pershina A. G. Aleksandra Gennadievna, Minin A. S. Artem, Mekhaev A. V. Alexander, Ivanov V. V. Vladimir, Lezhava S. P. Sofiya, Zakharova A. A. Alexandra, Byzov I. V. Iliya, Uimin M. A. Mikhail, Krasnov V. P. Victor, Ogorodova L. M. Ludmila
Resumo:Title screen
The surface modification of Fe3O4-based magnetic nanoparticles (MNPs) with N-(phosphonomethyl)iminodiacetic acid (PMIDA) was studied, and the possibility of their use as magnetic resonance imaging contrast agents was shown. The effect of the added PMIDA amount, the reaction temperature and time on the degree of immobilization of this reagent on MNPs, and the hydrodynamic characteristics of their aqueous colloidal solutions have been systematically investigated for the first time. It has been shown that the optimum condition for the modification of MNPs is the reaction at 40 °C with an equimolar amount of PMIDA for 3.5 h. The modified MNPs were characterized by X-ray diffraction, transmission electron microscopy, Fourier transform infrared spectroscopy, thermogravimetric, and CHN elemental analyses. The dependence of the hydrodynamic characteristics of the MNP colloidal solutions on the concentration and pH of the medium was studied by the dynamic light scattering method. On the basis of the obtained data, we can assume that the PMIDA molecules are fixed on the surface of the MNPs as a monomolecular layer. The modified MNPs had good colloidal stability and high magnetic properties. The calculated relaxivities r2 and r1 were 341 and 102 mmol-1 s-1, respectively. The possibility of using colloidal solutions of PMIDA-modified MNPs as a T2 contrast agent for liver studies in vivo (at a dose of 0.6 mg kg-1) was demonstrated for the first time.
Режим доступа: по договору с организацией-держателем ресурса
Idioma:inglês
Publicado em: 2018
Assuntos:
электронный ресурс
труды учёных ТПУ
магнитные наночастицы
магнитно-резонансная томография
коллоидные растворы
светорассеяние
контрастные средства
Acesso em linha:https://doi.org/10.1021/acs.langmuir.7b04023
Formato: Recurso Electrónico Capítulo de Livro
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=666740

Registos relacionados

Registos relacionados